I agree that this site is using cookies. You can find further informations here.
X
Nitta, Hiroaki
195  results:
Search for persons X
?
1

HER2 Intratumoral Heterogeneity in Breast Cancer, an Evolvi..:

Hou, Yanjun ; Nitta, Hiroaki ; Li, Zaibo
Cancers.  15 (2023)  10 - p. 2664 , 2023
Link: https://doi.org/10.3390/..
 
?
2

Artificial intelligence reveals features associated with br..:

Huang, Zhi ; Shao, Wei ; Han, Zhi...
npj Precision Oncology.  7 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
3

HER2 Gene Protein Assay: A Robust Tool for Evaluating HER2 ..:

Shafi, Saba ; Nitta, Hiroaki ; Shah, Manan...
American Journal of Clinical Pathology.  159 (2023)  5 - p. 464-473 , 2023
Link: https://doi.org/10.1093/..
 
?
4

Immunohistochemistry: Roche Tissue Diagnostics Perspective:

, In: Handbook of Practical Immunohistochemistry,
Nitta, Hiroaki ; Robida, Mark D. ; Polaske, Nate - p. 77-85 , 2022
Link: https://doi.org/10.1007/..
 
?
5

Predictive significance of HER2 intratumoral heterogeneity,..:

Horii, Rie ; Nitta, Hiroaki ; Nojima, Masanori...
Virchows Archiv.  479 (2021)  1 - p. 13-21 , 2021
Link: https://doi.org/10.1007/..
 
?
6

M2 tumor-associated macrophages play important role in pred..:

Arole, Vidya ; Nitta, Hiroaki ; Wei, Lai...
Breast Cancer Research and Treatment.  188 (2021)  1 - p. 37-42 , 2021
Link: https://doi.org/10.1007/..
 
?
7

The assessment of HER2 status and its clinical implication ..:

Hou, Yanjun ; Nitta, Hiroaki ; Parwani, Anil V..
Diagnostic Histopathology.  26 (2020)  2 - p. 61-68 , 2020
Link: https://doi.org/10.1016/..
 
?
8

Exploratory analysis of immune checkpoint receptor expressi..:

Wesolowski, Robert ; Stiff, Andrew ; Quiroga, Dionisia...
BMC Cancer.  20 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
9

Details of human epidermal growth factor receptor 2 status ..:

Hiraoka, Nobuyoshi ; Nitta, Hiroaki ; Ohba, Akihiro...
Human Pathology.  105 (2020)  - p. 9-19 , 2020
Link: https://doi.org/10.1016/..
 
?
10

HER2 intratumoral heterogeneity is independently associated..:

Shen, Tiansheng ; Nitta, Hiroaki ; Wei, Lai..
Breast Cancer Research and Treatment.  181 (2020)  3 - p. 519-527 , 2020
Link: https://doi.org/10.1007/..
 
?
11

Intratumoral Estrogen Receptor Heterogeneity of Expression ..:

Masuda, Shinobu ; Nitta, Hiroaki ; Kelly, Brian D....
Journal of Histochemistry & Cytochemistry.  67 (2019)  8 - p. 563-574 , 2019
Link: https://doi.org/10.1369/..
 
?
12

PD-L1 and CD8 are associated with deficient mismatch repair..:

Hou, Yanjun ; Nitta, Hiroaki ; Parwani, Anil V..
Human Pathology.  86 (2019)  - p. 108-114 , 2019
Link: https://doi.org/10.1016/..
 
?
13

Identification of HER2 Immunohistochemistry-Negative, FISH-..:

Gibbons-Fideler, I-sanna ; Nitta, Hiroaki ; Murillo, Adrian...
American Journal of Clinical Pathology.  151 (2018)  2 - p. 176-184 , 2018
Link: https://doi.org/10.1093/..
 
?
14

Evaluation of Immune Reaction and PD-L1 Expression Using Mu..:

Hou, Yanjun ; Nitta, Hiroaki ; Wei, Lai...
Clinical Breast Cancer.  18 (2018)  2 - p. e237-e244 , 2018
Link: https://doi.org/10.1016/..
 
?
15

HER2 Gene Protein Assay Is Useful to Determine HER2 Status ..:

Hou, Yanjun ; Nitta, Hiroaki ; Li, Zaibo
American Journal of Clinical Pathology.  , 2017
Link: https://doi.org/10.1093/..
 
1-15